JP2013508279A5 - - Google Patents

Download PDF

Info

Publication number
JP2013508279A5
JP2013508279A5 JP2012534259A JP2012534259A JP2013508279A5 JP 2013508279 A5 JP2013508279 A5 JP 2013508279A5 JP 2012534259 A JP2012534259 A JP 2012534259A JP 2012534259 A JP2012534259 A JP 2012534259A JP 2013508279 A5 JP2013508279 A5 JP 2013508279A5
Authority
JP
Japan
Prior art keywords
compound
group
salt
alkyl
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2012534259A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013508279A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/052126 external-priority patent/WO2011046851A1/en
Publication of JP2013508279A publication Critical patent/JP2013508279A/ja
Publication of JP2013508279A5 publication Critical patent/JP2013508279A5/ja
Withdrawn legal-status Critical Current

Links

JP2012534259A 2009-10-15 2010-10-11 スピロピペリジン化合物および糖尿病治療のためのその医薬用途 Withdrawn JP2013508279A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US25183909P 2009-10-15 2009-10-15
US61/251,839 2009-10-15
US30333410P 2010-02-11 2010-02-11
US61/303,334 2010-02-11
PCT/US2010/052126 WO2011046851A1 (en) 2009-10-15 2010-10-11 Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes

Publications (2)

Publication Number Publication Date
JP2013508279A JP2013508279A (ja) 2013-03-07
JP2013508279A5 true JP2013508279A5 (zh) 2013-11-07

Family

ID=43719548

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012534259A Withdrawn JP2013508279A (ja) 2009-10-15 2010-10-11 スピロピペリジン化合物および糖尿病治療のためのその医薬用途

Country Status (24)

Country Link
US (1) US8383642B2 (zh)
EP (1) EP2488500A1 (zh)
JP (1) JP2013508279A (zh)
KR (1) KR20120051777A (zh)
CN (1) CN102574807A (zh)
AR (1) AR078522A1 (zh)
AU (1) AU2010307094A1 (zh)
BR (1) BR112012008889A2 (zh)
CA (1) CA2777775A1 (zh)
CL (1) CL2012000921A1 (zh)
CO (1) CO6531458A2 (zh)
CR (1) CR20120177A (zh)
DO (1) DOP2012000105A (zh)
EA (1) EA201270560A1 (zh)
EC (1) ECSP12011799A (zh)
IL (1) IL218344A0 (zh)
MA (1) MA33662B1 (zh)
MX (1) MX2012004420A (zh)
NZ (1) NZ598972A (zh)
PE (1) PE20121437A1 (zh)
TN (1) TN2012000152A1 (zh)
TW (1) TW201124415A (zh)
WO (1) WO2011046851A1 (zh)
ZA (1) ZA201202560B (zh)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA108069C2 (uk) 2009-03-23 2015-03-25 Гленмарк Фармасьютікалс, С.А. Злиті піримідиндіонові похідні як модулятори trpa1
EP2411395B1 (en) 2009-03-23 2013-05-29 Glenmark Pharmaceuticals S.A. Furopyrimidinedione derivatives as trpa1 modulators
AR078948A1 (es) * 2009-11-30 2011-12-14 Lilly Co Eli Compuestos de espiropiperidina, composicion farmaceutica que lo comprenden y su uso para preparar un medicamento util para tratar la diabetes
NZ601408A (en) 2009-12-25 2013-12-20 Mochida Pharm Co Ltd Novel 3-hydroxy-5-arylisothiazole derivative
CA2813639A1 (en) 2010-10-08 2012-04-12 Mochida Pharmaceutical Co. Ltd. Cyclic amide derivative
AU2012229325B2 (en) 2011-03-11 2015-07-09 Intercontinental Great Brands Llc System and method of forming multilayer confectionery
RU2013152631A (ru) 2011-04-27 2015-06-10 Мотида Фармасьютикал Ко., Лтд. Новое 3-гидроксиизотиазол-1-окидное производное
EP2716636A4 (en) 2011-04-28 2014-11-26 Mochida Pharm Co Ltd CYCLIC AMIDE DERIVATIVE
TWI537262B (zh) * 2011-08-17 2016-06-11 美國禮來大藥廠 供治療糖尿病使用之新穎1,2,3,4-四氫喹啉衍生物
WO2013139341A1 (en) * 2012-03-20 2013-09-26 Syddansk Universitet Gpr120 receptor modulators
WO2013185766A1 (en) * 2012-06-15 2013-12-19 Syddansk Universitet Gpr120 receptor modulators
CN104812748B (zh) 2012-11-16 2017-10-24 百时美施贵宝公司 二氢吡唑gpr40调节剂
KR101569522B1 (ko) * 2013-04-18 2015-11-17 현대약품 주식회사 신규한 3-(4-(벤질옥시)페닐)헥스-4-이노익 산 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 대사성 질환의 예방 또는 치료용 약학적 조성물
MX2016006337A (es) * 2013-11-14 2016-09-06 Cadila Healthcare Ltd Compuestos heterociclicos novedosos.
US20150351889A1 (en) 2014-06-05 2015-12-10 Vivex Biomedical Inc. Dynamic Biometric Mesh
CN106715409B (zh) * 2014-10-17 2020-09-11 现代药品株式会社 包含3-(4-(苄氧基)苯基)-4-己炔酸衍生物及其它有效成分的代谢性疾病的预防或治疗用复合制剂
CN109666027A (zh) * 2017-10-17 2019-04-23 中国科学院上海药物研究所 一类酰胺结构的gpr40激动剂化合物及其用途
DK3737470T5 (da) 2018-01-08 2024-05-27 Celon Pharma Sa 3-phenyl-4-hexynsyrederivater som gpr40-agonister
EP4227302A1 (en) 2018-02-13 2023-08-16 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
EP3781556A1 (en) 2018-04-19 2021-02-24 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
ES2962674T3 (es) 2018-07-13 2024-03-20 Gilead Sciences Inc Inhibidores PD-1/PD-L1
EP3870566A1 (en) 2018-10-24 2021-09-01 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
BR112022006546A2 (pt) 2019-10-07 2022-08-30 Kallyope Inc Agonistas de gpr119
KR20230012597A (ko) 2020-05-19 2023-01-26 칼리오페, 인크. Ampk 활성화제
WO2021263039A1 (en) 2020-06-26 2021-12-30 Kallyope, Inc. Ampk activators

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828440B2 (en) * 2001-04-18 2004-12-07 Euro-Celtique, S.A. Spiroindene and spiroindane compounds
CN101108825A (zh) * 2003-04-04 2008-01-23 麦克公司 作为黑皮质素-4受体激动剂的酰化螺哌啶衍生物
JP2007510662A (ja) * 2003-11-04 2007-04-26 エリクシアー ファーマシューティカルズ, インコーポレイテッド 治療化合物およびその使用
US7834013B2 (en) 2003-11-19 2010-11-16 Glaxosmithkline Llc Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to GPR40
ES2433466T3 (es) 2004-02-27 2013-12-11 Amgen, Inc Compuestos, composiciones farmacéuticas y métodos para su uso en el tratamiento de trastornos metabólicos
US7517910B2 (en) * 2004-03-30 2009-04-14 Takeda Pharmaceutical Company Limited Alkoxyphenylpropanoic acid derivatives
EP1924546A1 (en) * 2005-09-14 2008-05-28 Amgen, Inc Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
AU2007292816B2 (en) 2006-09-07 2011-11-17 Amgen Inc. Benzo-fused compounds for use in treating metabolic disorders
MX2010004435A (es) * 2007-10-26 2010-05-13 Japan Tobacco Inc Compuestos espiro y uso farmaceutico de los mismos.
ES2469824T3 (es) * 2007-11-21 2014-06-20 Janssen Pharmaceutica N.V. Espiropiperidinas para su uso como inhibidores de la triptasa
AR078948A1 (es) 2009-11-30 2011-12-14 Lilly Co Eli Compuestos de espiropiperidina, composicion farmaceutica que lo comprenden y su uso para preparar un medicamento util para tratar la diabetes

Similar Documents

Publication Publication Date Title
JP2013508279A5 (zh)
JP2013512277A5 (zh)
JP2013518107A5 (zh)
JP2012525393A5 (zh)
JP2009535307A5 (zh)
JP2010077141A5 (zh)
JP2016530259A5 (zh)
JP2014511891A5 (zh)
JP2013510120A5 (zh)
JP2012505836A5 (zh)
JP2009535352A5 (zh)
JP2013509429A5 (zh)
JP2011504903A5 (zh)
JP2009523760A5 (zh)
JP2011528713A5 (zh)
JP2020507589A5 (zh)
JP2013507439A5 (zh)
JP2009504763A5 (zh)
JP2014505107A5 (zh)
JP2013500986A5 (zh)
JP2013534248A5 (zh)
JP2014508804A5 (zh)
JP2007302689A5 (zh)
JP2011246469A5 (zh)
JP2019515908A5 (zh)